🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Clindamycin + BPO

Found 18 matching trials

Cutibacterium Dermal Colonization: Implications for Total Hip Arthroplasty

PHASE4

This study is being done to investigate the colonization rate(growth rate) ...

Status

Unknown

Location

Colorado Joint Replacement

Start Date

2019-02-02

Trial ID

NCT03849885

Treatments Being Tested

Benzoyl peroxide gel

Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris

PHASE3

Actavis has developed a generic formulation of clindamycin 1.2% and benzoyl...

Status

Completed

Location

Alliance Dermatology

Start Date

2015-05

Trial ID

NCT02616614

Treatments Being Tested

Onexton Clindamycin/benzoyl peroxide gel Placebo

Two-week Study to Compare the Tolerance and Irritation Potential of Two Combination Topical Gel Acne Medications

PHASE4

This is a single-blind (blinded expert grader), randomized, half-face study...

Status

Completed

Location

cyberDERM

Start Date

2009-05

Trial ID

NCT00926367

Treatments Being Tested

Clindamycin and benzoyl peroxide benzoyl peroxide 2.5% and adapalene 0.1% gel

Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications

PHASE4

This is a single-blind (blinded expert grader) study that will enroll 25-30...

Status

Completed

Location

cyberDERM

Start Date

2009-08

Trial ID

NCT01015638

Treatments Being Tested

Clindamycin and BPO 5% gel Clindamycin phosphate and benzoyl peroxide 2.5% gel.

Comparative Efficacy and Safety of Benzoyl Peroxide Used in Combination With Clindamycin vs. Benzoyl Peroxide Used in Combination With Clindamycin and Doxycycline in the Treatment of Moderate Acne

PHASE4

To compare the efficacy and safety of Benzoyl peroxide used in combination ...

Status

Completed

Location

Center for Dermatology, Cosmetic and Laser Surgery

Start Date

2007-08

Trial ID

NCT00837213

Treatments Being Tested

Benzoyl peroxide with clindamycin Benzoyl peroxide with clindamycin and doxycycline

Experience With Topical Acne Treatment

EARLY_PHASE1

Acne is a chronic condition that typically requires the use of multiple med...

Status

Active Not Recruiting

Location

Wake Forest University Health Sciences

Start Date

2024-02-15

Trial ID

NCT05582434

Treatments Being Tested

clindamycin phosphate 1.2%/adapalene 0.15%/BPO 3.1% gel adapalene 0.3%/BPO 2.5% gel and compounded clindamycin phosphate 1.2% gel Compounded BPO 2.5% gel, adapalene 0.1% gel, and compounded clindamycin phosphate 1.2% gel

Comparison of the Efficacy and Safety of Clindamycin + Benzoyl Peroxide Formulation With Azelaic Acid Formulation in the Treatment of Acne Vulgaris

PHASE4

This is a randomized, comparator-controlled, single-blind, parallel-group s...

Status

Completed

Location

GSK Investigational Site

Start Date

2014-02-21

Trial ID

NCT02058628

Treatments Being Tested

Clindamycin + BPO Azelaic acid

Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo

PHASE4

This study is to evaluate the safety, pharmacokinetics, and treatment effec...

Status

Recruiting

Location

Dermatology Trial Associates

Start Date

2026-04-01

Trial ID

NCT07524946

Treatments Being Tested

CABTREO is a fixed-combination product of clindamycin phosphate 1.2%/BPO 3.1%/adapalene 0.15%.

Study STF115288, a Clinical Confirmation Study of GI148512 in the Treatment of Acne Vulgaris in Japanese Subjects

PHASE3

This is a multicenter, randomized, double-blinded, vehicle-controlled, para...

Status

Completed

Location

GSK Investigational Site

Start Date

2011-07

Trial ID

NCT01400932

Treatments Being Tested

GI148512 vehicle gel

W0261-101: A Phase 1, Single Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Clindamycin From Clindamycin 1%-Benzoyl Peroxide 3% Gel, Topical Gel (Clindamycin 1%- Benzoyl Peroxide 5%), and Once Daily Gel (Clindamycin 1%-Benzoyl Peroxide 5%) in Subjects With Acne

PHASE1

This study was conducted to determine if the bioavailability of clindamycin...

Status

Completed

Location

Multiple Locations

Start Date

2010-05-06

Trial ID

NCT01132443

Treatments Being Tested

Clindamycin 1%-Benzoyl Peroxide (BPO) 3% Gel,

Previous Next